ReviewPharmaceutics2022

Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.

Frédéric Frézard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.